HCA Just Called a 2027 Timeout — and the Tape Has Already Paid for It
A clean third quarter, a flat-EBITDA 2027 sketch, a $400M exchange hole, and the first real proof the resiliency program exists outside a slide deck.
HCA · Earnings Call · 2026-10-27
A Guidance Pause in a Sector That Never Pauses
The third quarter itself was fine. Same-facility adjusted admissions grew 3%, ER visits 5.1%, and Michael Marks told the call the company expects to land in the upper half of its 2026 ranges. Nothing in the quarter was alarming. The alarming thing was a sentence four paragraphs into Sam Hazen's prepared remarks: “we anticipate our earnings in 2027 will be generally consistent with 2026” — Samuel N. Hazen, Chief Executive Officer · 2026-10-27. That is a plateau, and it is the first time in this whole exchange-and-premium-subsidy cycle that HCA has broken frame from its long-term growth algorithm. The mechanics are brutal and simple. Two things reverse at once. First, the payer-mix hole: “the payer mix shift from exchanges to uninsured resulted in an unfavorable impact on adjusted EBITDA of approximately $400 million in the quarter” — Michael A. Marks, Chief Financial Officer · 2026-10-27. Second, the Medicaid supplemental program gravy train. The 2026 incremental net benefit range was raised to $600–800M — but 2027 gets roughly $550–650M less, because those grandfather approvals from Virginia, Florida and Georgia were payments for services rendered in prior years. They inflate this year and cannot recur. So the entire 2027 story reduces to one arithmetic contest: 2–3% volume growth plus pricing plus cost savings versus a half-billion-dollar supplemental cliff and whatever exchange attrition is left. Management's answer is "flat." That is a remarkably honest answer for a company with 22 consecutive quarters of volume growth.What Quietly Fell Off the Script
The most telling change is what disappeared. The premium tax credit — a top-five keyword for HCA as recently as the first and third quarters of 2026 — is simply absent from the current top thirty. exchange volume is still there, but it has changed register completely. A quarter ago the debate was whether the migration was 80–85% or truly one-for-one; Mike settled it in July with “our data is telling us now that it is closer to 1-for-1” — Michael A. Marks, Chief Financial Officer (CFO) · 2026-07-24. Now it is a run-rate fact, and the incremental news is directional: exchange equivalent admissions fell 19% year over year but rose roughly 8% sequentially from Q2 to Q3. First sequential improvement of the cycle. Uninsured is 10.5% of total equivalent admissions versus 8.5%. Sam's July planning assumption — “loss of coverage will be less than 2026” — Samuel N. Hazen, Chief Executive Officer (CEO) · 2026-07-24 — is holding. What replaced the exchange debate in the Q&A is 340B. Ann Hynes asked the question, and Mike's answer was the single most interesting thing said all morning: “We were pleased with the construct that is a part of the proposed rule as it relates to a budget neutral reallocation of 340B. It would benefit us. We have not... sizing that publicly at this point” — Michael A. Marks, Chief Financial Officer · 2026-10-27. Read that carefully. A proposed Medicare OPPS rule that redistributes 340B reimbursement away from participating entities and toward non-participants is a structural, multi-billion-dollar-class tailwind for for-profit hospital operators — and it is not in the guidance at all. Neither is it sized. If it finalizes, 2027 is not flat. The other feared 2027 headwind got de-risked in a single answer. On HR1 able bodied adults work requirements, Mike walked through the math out loud: expansion states are 40% of Medicaid, strip out seniors, disabled, children and the medically frail, and the requirement touches 15–20% of that base. Net conclusion: "a bit of a modest impact in full year 2027." A headline policy risk repriced down to background noise.The Cost Line Blinked First
Here is the number almost nobody will talk about on the follow-up calls. Same-facility cost per equivalent admission, ex-supplemental, was essentially flat year over year and down 40 basis points sequentially — in a quarter that always goes the other way, because that is when merit increases land. “they were down 40 basis points sequentially from second quarter to third quarter” — Michael A. Marks, Chief Financial Officer · 2026-10-27. That is the first hard P&L evidence that the wide resiliency program is real and not narrative. Marks laid out the four pillars — revenue integrity, asset optimization, variable cost, fixed cost — and the sequencing matters: revenue integrity and patient flow come first because they need no capital, just software and discipline.A fair skeptic's note: HCA has been making this speech for six quarters, and the language barely changes. Sam in July: “this has been an opportunity for us for years. We just did not have the tools to get after it” — Samuel N. Hazen, Chief Executive Officer (CEO) · 2026-07-24. Again this quarter: “Heretofore, we did not have that ability because we did not have the capabilities nor the technology” — Samuel N. Hazen, Chief Executive Officer · 2026-10-27. Same words, different quarter. The difference is that this time the cost line agreed with the slide.We are nowhere near the back 9 here on asset optimization and feel good about the work ahead there.